Buy Clopidogrel Sulfate (Clopidogrel Bisulfate) Powder Raw Anti-platelet Drug Online CAS 120202-66-6
Clopidogrel Sulfate Specification
Product Name: Clopidogrel sulfate
CAS: 120202-66-6
Level: Pharmaceutical Grade
Content: 99%
Appearance: white powder
Packing: 25KG/ cardboard drum detachable
Category: Pharmaceutical raw materials
Industry: Medicine
Area: Antithrombotic drugs
Deferred product: tablet
Use: Mainly used for the treatment of acute myocardial infarction
Dosage: The recommended dose of Plavix is 75mg per day, with or without food, no need to adjust the dose for elderly patients
What is Clopidogrel Sulfate?
Clopidogrel bisulfate is an anti-platelet drug, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel prevents blood clots by irreversibly binding to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP) from activating platelets. It belongs to a class of drugs called P2Y12 inhibitors.
Clopidogrel Sulfate Certificate of Analysis
Product name |
CLOPIDOGREL BISULFATE |
CAS No. |
120202-66-6 |
Outer Packing |
25KG/drum |
Production date |
2016.04.18 |
Shelf life |
208.04.14 |
Standard adopted |
USP36 |
Items of analysis |
Specification |
Results |
Appearance |
White to off- white powder |
Off- white powder |
Solubility |
Freely soluble in methanol and water,practically;insoluble in ether |
Complies |
Identification |
A. The IR spectrum of sample recorded as KBr pellet is concordant with similarly recorded spectrum of working standard. |
Complies |
Identification |
B. The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay. |
Complies |
Loss on drying |
≤0.5% |
0.31% |
Residue on ignition |
≤0.1% |
0.08% |
Related compound A |
≤ 0.2% |
0.18% |
Related compound B |
≤ 0.3% |
Not detected |
Related compound C |
≤1.0% |
0.38% |
Any other impurity |
≤ 0.1% |
0.05% |
Total impurities |
≤ 1.5% |
0.63% |
Assay HPLC |
≥98.0% |
98.5% |
Conclusion |
Qualified |